17114658

Source:http://linkedlifedata.com/resource/pubmed/id/17114658

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0282460, umls-concept:C0684249, umls-concept:C0995188, umls-concept:C1522326
pubmed:issue	33
pubmed:dateCreated	2006-11-20
pubmed:abstractText	To determine the efficacy of cetuximab in patients with recurrent or progressive non-small-cell lung cancer (NSCLC) after receiving at least one prior chemotherapy regimen.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/cetuximab
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1527-7755
pubmed:author	pubmed-author:AnsariRafatR, pubmed-author:BonomiPhilipP, pubmed-author:GovindanRamaswamyR, pubmed-author:HannaNasserN, pubmed-author:JännePasi APA, pubmed-author:LilenbaumRogerioR, pubmed-author:LynchThomasT
pubmed:issnType	Electronic
pubmed:day	20
pubmed:volume	24
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	5253-8
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:17114658-Adult, pubmed-meshheading:17114658-Aged, pubmed-meshheading:17114658-Antibodies, Monoclonal, pubmed-meshheading:17114658-Antineoplastic Agents, pubmed-meshheading:17114658-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:17114658-Disease Progression, pubmed-meshheading:17114658-Disease-Free Survival, pubmed-meshheading:17114658-Drug Administration Schedule, pubmed-meshheading:17114658-Female, pubmed-meshheading:17114658-Humans, pubmed-meshheading:17114658-Lung Neoplasms, pubmed-meshheading:17114658-Male, pubmed-meshheading:17114658-Middle Aged, pubmed-meshheading:17114658-Neoplasm Recurrence, Local, pubmed-meshheading:17114658-Neoplasm Staging, pubmed-meshheading:17114658-Receptor, Epidermal Growth Factor, pubmed-meshheading:17114658-Survival Analysis, pubmed-meshheading:17114658-Treatment Outcome, pubmed-meshheading:17114658-Tumor Markers, Biological
pubmed:year	2006
pubmed:articleTitle	Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer.
pubmed:affiliation	Indiana University, Indianapolis, USA. nhanna@iupui.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II